metformin mylan 850 mg filmdragerad tablett
mylan ab - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
mitforgen 850 mg filmdragerad tablett
viatris limited - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
metformin aristo 850 mg filmdragerad tablett
aristo pharma gmbh - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
sotalol 2care4 160 mg tablett
2care4 aps - sotalolhydroklorid - tablett - 160 mg - sotalolhydroklorid 160 mg aktiv substans - sotalol
sotalol viatris 40 mg tablett
viatris limited - sotalolhydroklorid - tablett - 40 mg - sotalolhydroklorid 40 mg aktiv substans - sotalol
sotacor 80 mg tablett
cheplapharm arzneimittel gmbh - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans; laktosmonohydrat hjälpämne - sotalol
sotalol viatris 80 mg tablett
viatris limited - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans - sotalol
sotalol 2care4 80 mg tablett
2care4 aps - sotalolhydroklorid - tablett - 80 mg - sotalolhydroklorid 80 mg aktiv substans - sotalol
eucreas
novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).